CNBC February 19, 2025
Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol.
That’s according to new government-funded research published in JAMA Psychiatry last week.
It was a small study of just 48 adults that lasted over two months, but it appears to be the first clinical trial confirming that so-called GLP-1 drugs could help reduce the risks of consuming too much alcohol. Multiple analyses of real-world data, along with studies in animals, have suggested that link.
The findings could be huge for those with alcohol-use disorder, which is when a person can’t stop drinking even when it puts their health and safety at risk. The condition affects almost 30 million people in the U.S., and encompasses...
Today's Sponsors
Today's Sponsor